Arch Biopartners Inc. (ACHFF)

Arch Biopartners Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb 13, 2026	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Market Capitalization	47	61	84	51	136	84
Market Cap Growth	-42.53%	-27.29%	65.75%	-62.68%	61.25%	34.83%
Enterprise Value	49	63	88	54	139	89
Last Close Price	0.70	0.92	1.30	0.81	2.18	1.36
PS Ratio	237.38	308.46	53.51	34.58	193.39	27.41
PB Ratio	-16.88	-21.93	-26.11	-12.45	-41.73	-27.44
P/OCF Ratio	-	-	-	-	389.08	-
EV/Sales Ratio	247.67	317.72	55.97	37.12	197.59	28.88
Debt / Equity Ratio	-0.73	-0.73	-0.64	-0.91	-0.99	-1.33
Asset Turnover	0.53	0.53	2.01	2.21	0.59	2.28
Quick Ratio	0.02	0.02	0.17	0.19	0.21	0.83
Current Ratio	0.03	0.03	0.18	0.20	0.22	0.84
Return on Assets (ROA)	-136.33%	-136.33%	-205.03%	-201.92%	-37.89%	-30.04%
Return on Capital Employed (ROCE)	29.20%	29.20%	79.50%	60.30%	46.20%	157.30%
Earnings Yield	-2.37%	-1.82%	-3.45%	-4.85%	-0.76%	-1.10%
Buyback Yield / Dilution	-3.51%	-3.51%	-1.46%	-0.49%	-1.36%	-2.34%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.